Tesamorelin Research Peptide
Tesamorelin is a full-length 44-amino-acid GHRH analogue with an N-terminal trans-3-hexenoyl group that protects it from DPP-4 breakdown.
4 listed Tesamorelin presentations
Each presentation is a separate specification with its own product code. Open one to add it to your inquiry cart or to ask for a quote on WhatsApp. Pricing, availability and lot documents are confirmed for each order.
| Presentation | Per vial | Per box | Product code |
|---|---|---|---|
| Tesamorelin 2 mg → | 2 mg | 10 vials | TSM2 |
| Tesamorelin 5 mg → | 5 mg | 10 vials | TSM5 |
| Tesamorelin 10 mg → | 10 mg | 10 vials | TSM10 |
| Tesamorelin 20 mg → | 20 mg | 10 vials | TSM20 |
Amounts are per vial. mg, IU and mL describe different quantities and are not interchangeable. For laboratory research use only.
About Tesamorelin
Tesamorelin keeps the complete 44-amino-acid sequence of human growth hormone-releasing hormone and adds a trans-3-hexenoyl group to the N-terminal tyrosine. This single modification protects it from DPP-4 cleavage, the main route by which native GHRH is inactivated.
It therefore sits between the short GHRH(1-29) analogues, sermorelin and CJC-1295, and the native hormone: full length like GHRH, but stabilized.
Research context
Tesamorelin is used in research on GHRH-receptor signaling, growth hormone and IGF-1 regulation and visceral adipose tissue biology in preclinical models, and as a comparator for GHRH(1-29) analogues.
Tesamorelin is also the active ingredient of licensed pharmaceutical products in some markets. The material listed here is supplied for laboratory research only; it is not a pharmaceutical product and must not be used as one.
What to confirm for Tesamorelin
Check these points with our team before you order:
- The strength per vial; each fill is a separate presentation with its own code.
- Whether tesamorelin alone or the tesamorelin + ipamorelin blend fits your design.
- The number of boxes you need and the US delivery destination.
- Which lot documents you require before ordering, such as an identity or purity report.
Tesamorelin: frequently asked questions
How does tesamorelin differ from sermorelin?
Sermorelin is the 29-amino-acid active fragment of GHRH without further modification. Tesamorelin is the full 44-amino-acid sequence with an N-terminal hexenoyl group that makes it resistant to DPP-4.
Which Tesamorelin presentations are listed?
4 presentations are listed: 2 mg (TSM2), 5 mg (TSM5), 10 mg (TSM10), 20 mg (TSM20). Each is packed 10 vials per box, and every presentation has its own specification page and product code.
How do I request a quote for Tesamorelin?
Open the presentation you need and use Ask price to message PureForm Biosciences on WhatsApp, or add several materials to the inquiry cart and send them together. Pricing, current availability and lot documents are confirmed in that conversation.
Related research materials
- Tesamorelin + Ipamorelin Blend →Tesamorelin 10 mg and ipamorelin 5 mg combined per vial.
- Sermorelin →GHRH(1-29)-NH₂, the shortest fully active GHRH fragment.
- CJC-1295 →Tetrasubstituted GHRH(1-29) analogue, listed with and without DAC.
- Ipamorelin →Selective ghrelin-receptor (GHS-R1a) agonist pentapeptide.
Research Use Only. Tesamorelin is supplied strictly for laboratory research. It is not a drug, supplement or medical product and is not for human or veterinary consumption.